Single‐cell RNA sequencing reveals immune microenvironment of small cell lung cancer‐associated malignant pleural effusion

We used 10 × genomics single‐cell transcriptome sequencing technology to reveal the tumor immune microenvironment characteristics of small cell lung cancer (SCLC) in a patient with malignant pleural effusion (MPE). A total of 8008 high‐quality cells were finally obtained for subsequent bioinformatic...

Full description

Saved in:
Bibliographic Details
Published inThoracic cancer Vol. 15; no. 1; pp. 98 - 103
Main Authors Wang, Shuyan, An, Jing, Hu, Xueru, Zeng, Tingting, Li, Ping, Qin, Jiangyue, Shen, Yongchun, Chen, Mei, Wen, Fuqiang
Format Journal Article
LanguageEnglish
Published Melbourne John Wiley & Sons Australia, Ltd 01.01.2024
John Wiley & Sons, Inc
Wiley
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:We used 10 × genomics single‐cell transcriptome sequencing technology to reveal the tumor immune microenvironment characteristics of small cell lung cancer (SCLC) in a patient with malignant pleural effusion (MPE). A total of 8008 high‐quality cells were finally obtained for subsequent bioinformatic analysis, which were divided into 10 cell clusters further identified as B cells, T cells, myeloid cells, NK cells, and cancer cells. Such SCLC related genes as NOTCH1, MYC, TSC22D1, SOX4, BLNK, YBX3, VIM, CD8A, CD8B, and KLF6 were expressed in different degrees during differentiation of T and B cells. Different ligands and receptors between T, B and tumor cells almost interact through MHC II, IL‐16, galectin, and APP signaling pathway. We use 10 × genomics single‐cell transcriptome sequencing technology to reveal the tumor immune microenvironment characteristics of small cell lung cancer (SCLC) in malignant pleural effusion (MPE). A total of 8008 high‐quality cells were obtained and divided as B cells, T cells, myeloid cells, NK cells, and cancer cells (a). Such SCLC related genes as NOTCH1, MYC, TSC22D1, SOX4, BLNK, YBX3, VIM, CD8A, CD8B, and KLF6 were expressed in different degrees during differentiation of CD4+ T cells (b), CD8+ T cells (c), and B cells (d). Different ligands and receptors between T, B, and tumor cells almost interact through MHC II (e), IL‐16 (f), galectin (g), and APP (h) signaling pathway.
Bibliography:Shuyan Wang and Jing An contributed equally.
ISSN:1759-7706
1759-7714
DOI:10.1111/1759-7714.15145